Find Research Outputs

Search concepts
Selected Filters
2019
1 Citation (Scopus)

[ 99 mTc-HYNIC-N-dodecylamide]:a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging

Isaac-Olivé, K., Ocampo-García, B. E., Aranda-Lara, L., Santos-Cuevas, C. L., Jiménez-Mancilla, N. P., Luna-Gutiérrez, M. A., Medina, L. A., Nagarajan, B., Sabnis, N., Raut, S. L., Prokai, L. & Lacko, A. G., 14 Jan 2019, In : Nanoscale. 11, 2, p. 541-551 11 p.

Research output: Contribution to journalArticle

Lipoproteins
HDL Lipoproteins
Labeling
Imaging techniques
Acids
2 Citations (Scopus)

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer

Chen, X., Mangala, L. S., Mooberry, L., Bayraktar, E., Dasari, S. K., Ma, S., Ivan, C., Court, K. A., Rodriguez-Aguayo, C., Bayraktar, R., Raut, S., Sabnis, N., Kong, X., Yang, X., Lopez-Berestein, G., Lacko, A. G. & Sood, A. K., 15 Aug 2019, In : Oncogene. 38, 33, p. 6095-6108 14 p.

Research output: Contribution to journalArticle

MicroRNAs
Ovarian Neoplasms
Neoplasms
CD36 Antigens
Vascular Endothelial Growth Factor A
2 Citations (Scopus)

The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

Berney, E., Sabnis, N., Panchoo, M., Raut, S., Dickerman, R. & Lacko, A. G., 1 Jan 2019, In : Journal of Oncology. 2019, 1805841.

Research output: Contribution to journalArticle

Open Access
Scavenger Receptors
Glioblastoma
HDL Lipoproteins
Cell Cycle
Sirolimus
2018
6 Citations (Scopus)

Lipoproteins for therapeutic delivery: Recent advances and future opportunities

Raut, S., Dasseux, J. L., Sabnis, N. A., Mooberry, L. & Lacko, A., 1 Jan 2018, In : Therapeutic Delivery. 9, 4, p. 257-268 12 p.

Research output: Contribution to journalReview article

Lipoproteins
Neoplasms
Triglycerides
Therapeutics
Cholesterol
3 Citations (Scopus)

Reconstituted HDL: Drug delivery platform for overcoming biological barriers to cancer therapy

Raut, S., Mooberry, L., Sabnis, N., Garud, A., Dossou, A. S. & Lacko, A., 15 Oct 2018, In : Frontiers in Pharmacology. 9, OCT, 01154.

Research output: Contribution to journalReview article

Pharmaceutical Preparations
Neoplasms
Nanoparticles
Therapeutics
Technology
7 Citations (Scopus)

Scavenger receptor class B type 1 regulates neuroblastoma cell proliferation, migration and invasion

Panchoo, M. & Lacko, A., 1 Jan 2018, In : Biochemical and Biophysical Research Communications. 495, 1, p. 614-620 7 p.

Research output: Contribution to journalArticle

CD36 Antigens
Cell proliferation
Neuroblastoma
Cell Movement
Cell Proliferation
2016
9 Citations (Scopus)

Photophysical characterization of anticancer drug valrubicin in rHDL nanoparticles and its use as an imaging agent

Shah, S., Chib, R., Raut, S., Bermudez, J., Sabnis, N., Duggal, D., Kimball, J. D., Lacko, A. G., Gryczynski, Z. & Gryczynski, I., Feb 2016, In : Journal of Photochemistry and Photobiology B: Biology. 155, p. 60-65 6 p.

Research output: Contribution to journalArticle

valrubicin
lipoproteins
HDL Lipoproteins
Nanoparticles
drugs
28 Citations (Scopus)

Targeting the SR-B1 receptor as a gateway for cancer therapy and imaging

Mooberry, L. K., Sabnis, N. A., Panchoo, M., Nagarajan, B. & Lacko, A. G., 1 Jan 2016, In : Frontiers in Pharmacology. 7, DEC, 466.

Research output: Contribution to journalReview article

Scavenger Receptors
CD36 Antigens
Neoplasms
Therapeutics
Cholesterol Esters
2015
30 Citations (Scopus)

HDL as a drug and nucleic acid delivery vehicle

Lacko, A. G., Sabnis, N. A., Nagarajan, B. & McConathy, W. J., 1 Jan 2015, In : Frontiers in Pharmacology. 6, OCT, 1 p.

Research output: Contribution to journalArticle

HDL Lipoproteins
Nucleic Acids
Pharmaceutical Preparations
Nanoparticles
Cholesterol Esters